
CAS Number18877-64-0
SynonymsMFCD00070346; Palmitoyl-L-carnitine chloride; 3-carboxy-n,n,n-trimethyl-2-(palmitoyloxy)propan-1-aminium chloride; UNII:EIL57224QR; 1-Propanaminium, 3-carboxy-N,N,N-trimethyl-2-[(1-oxohexadecyl)oxy]-, chloride (1:1); EINECS 242-642-6; 3-Carboxy-N,N,N-trimethyl-2-(palmitoyloxy)-1-propanaminium chloride
Molecular FormulaC23H46NO4 · Cl
Molecular Weight436.07
Purity≥98 (TLC)%
Melting Point168-172ºC(lit.)
Appearancepowder
EINECS242-642-6
Symbol
Signal WordWarning
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 18877-64-0 |
| Catalog No. | 2A-2199669 |
| Chinese Name | 棕榈酰-L-肉碱盐酸盐 |
| Synonyms | MFCD00070346; Palmitoyl-L-carnitine chloride; 3-carboxy-n,n,n-trimethyl-2-(palmitoyloxy)propan-1-aminium chloride; UNII:EIL57224QR; 1-Propanaminium, 3-carboxy-N,N,N-trimethyl-2-[(1-oxohexadecyl)oxy]-, chloride (1:1); EINECS 242-642-6; 3-Carboxy-N,N,N-trimethyl-2-(palmitoyloxy)-1-propanaminium chloride |
| Molecular Formula | C23H46NO4 · Cl |
| Molecular Weight | 436.07 |
| Purity | ≥98 (TLC) |
| Melting Point | 168-172ºC(lit.) |
| Appearance | powder |
| Storage Condition | Refrigerated at -20°C, airtight, dry place |
| Application | L-Palmitoylcarnitine chloride is a long-chain acylcarnitine and fatty acid metabolite that accumulates in the muscle membrane during ischemia and disrupts the membrane lipid environment. L-Palmitoylca |
| EINECS | 242-642-6 |
| PubChem ID | 24898229 |
| MDL Number | MFCD00070346 |
| SMILES | [Cl-].CCCCCCCCCCCCCCCC(=O)O[C@H](CC(O)=O)C[N+](C)(C)C |
| InChI | 1S/C23H45NO4.ClH/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-23(27)28-21(19-22(25)26)20-24(2,3)4;/h21H,5-20H2,1-4H3;1H/t21-;/m1./s1 |
| InChI Key | GAMKNLFIHBMGQT-ZMBIFBSDSA-N |
| Beilstein/REAXYS | 4071005 |
| NACRES Code | NA.25 |
| UNSPSC | 12352211 |
| Hazard Symbols | transportation |
| MSDS | msds/201659_1_18877_64_0.pdf |
| Bioactivity | L-Palmitoylcarnitine chloride, a long-chain acylcarnitine and a fatty acid metabolite, accumulates in the sarcolemma and deranges the membrane lipid environment during ischaemia. L-Palmitoylcarnitine chloride inhibits KATP channel activity, without affecting the single channel conductance, through interaction with Kir6.2[1]. Related Catalog Research Areas >> Cardiovascular Disease Research Areas >> Metabolic Disease Signaling Pathways >> Membrane Transporter/Ion Channel >> Potassium Channel Target Kir6.2 Human Endogenous Metabolite In Vitro L-Palmitoylcarnitine (1 µM) inhibits KATP channel activity, without affecting the single channel conductance, through interaction with Kir6.2. L-Palmitoylcarnitine simultaneously enhances the ATP sensitivity of the channel (IC50 fell from 62 to 30 µM)[1]. Modulation of the membrane lipid environment caused by L-Palmitoylcarnitine alters the KATP channel function mainly through the interaction with endogenous PI cascade, especially PIP2[1]. References [1]. Haruna T, et al. Alteration of the membrane lipid environment by L-palmitoylcarnitine modulates K(ATP) channels in guinea-pig ventricular myocytes. Pflugers Arch. 2000;441(2-3):200-207. Chemical & Physical Properties Melting Point 168-172ºC(lit.) Molecular Formula C23H46ClNO4 Molecular Weight 436.069 Exact Mass 435.311523 PSA 63.60000 LogP 2.56440 InChIKey GAMKNLFIHBMGQT-ZMBIFBSDSA-N SMILES CCCCCCCCCCCCCCCC(=O)OC(CC(=O)O)C[N+](C)(C)C.[Cl-] Storage condition -20°C |
| Use of | L-Palmitoylcarnitine chloride, a long-chain acylcarnitine and a fatty acid metabolite, accumulates in the sarcolemma and deranges the membrane lipid environment during ischaemia. L-Palmitoylcarnitine chloride inhibits KATP channel activity, without affecting the single channel conductance, through interaction with Kir6.2[1]. Properties Name palmitoyl-l-carnitine chloride Synonym More Synonyms L-Palmitoylcarnitine chloride Biological Activity Description L-Palmitoylcarnitine chloride, a long-chain acylcarnitine and a fatty acid metabolite, accumulates in the sarcolemma and deranges the membrane lipid environment during ischaemia. L-Palmitoylcarnitine chloride inhibits KATP channel activity, without affecting the single channel conductance, through interaction with Kir6.2[1]. Related Catalog Research Areas >> Cardiovascular Disease Research Areas >> Metabolic Disease Signaling Pathways >> Membrane Transporter/Ion Channel >> Potassium Channel Human Endogenous Metabolite References [1]. Haruna T, et al. Alteration of the membrane lipid environment by L-palmitoylcarnitine modulates K(ATP) channels in guinea-pig ventricular myocytes. Pflugers Arch. 2000;441(2-3):200-207. Chemical & Physical Properties Exact Mass 435.311523 PSA 63.60000 LogP 2.56440 InChIKey GAMKNLFIHBMGQT-ZMBIFBSDSA-N SMILES CCCCCCCCCCCCCCCC(=O)OC(CC(=O)O)C[N+](C)(C)C.[Cl-] |
| Transport Info | Product name: Purity: 98.0% |
| MSDS Transport Info | Module 14. Shipping information 14.1 UN dangerous goods number European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.2 Names specified by the United Nations (UN) European Land Transport Dangerous Regulations: Non-dangerous goods IMDG Code: Non-dangerous goods International air transport dangerous goods regulations: non-dangerous goods 14.3 Transport hazard categories European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.4 Package group European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.5 Environmental hazards European Land Transport Dangerous Regulations: No International Maritime Transport Dangerous Regulations Maritime Pollutants: No International Air Transport Risk Regulations: No 14.6 Special reminder to users No data available |
| Related Products in Nutritional Ingredients | ||
|---|---|---|
| YEAST BETA-GLUCAN | 9051-09-2 | 2A-1199551 |
| BETA-GLUCAN | 160872-27-5 | 2A-1199552 |
| LAUROYL-L-CARNITINE CHLORIDE | 6919-91-1 | 2A-1199576 |
| Chlorella | 2A-2199617 | 2A-2199617 |
| Whey protein isolate | 2A-2199637 | 2A-2199637 |
| Conjugated linoleic acid | 22880-03-1 | 2A-2199674 |
| N-ACETYL-ALPHA-D-GLUCOSAMINE 6-PHOSPHATE DISODIUM SALT | 31281-59-1 | 2A-2199798 |
| L-Glutamic acid, N-[4-[(2-amino-3,4-dihydro-7-methyl-4-oxo-6-pteridinyl)amino]benzoyl]- | 2734707-85-6 | 2A-1199921 |
| kasugamycin 2%+tricyclazole 20%WP | 19408-46-9+41814-78-2 | 2A-2200002 |
| epoxiconazole 6%+tricyclazole 24%SC | 135319-73-2+41814-78-2 | 2A-2200004 |
| Browse all Nutritional Ingredients products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA